Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Warburg Gets a Boost from {Viagra}

This article was originally published in Start Up

Executive Summary

Warburg Pincus bought Pfizer's American Medical Systems, looking to create a platform to consolidate the very deconsolidated urology field. Warburg thinks it got a good price because AMS' penile implant sales have been hurt by Pfizer's {Viagra}, depressing the division's value. But the venture fund thinks {Viagra} will bring lots of new patients in for whom drug therapy won't work; moreover, it thinks it can add technology to AMS to differentiate it in this largely commoditized field. Warburg, in short, sees AMS as its specialized urology venture fund.

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

MT037016

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel